GlassScriptPhysician profile
Virginia Ott
NPI 1851536320
$7,782.42
in general payments reported to CMS, 2019-2025
39 companies · $681 in 2025
The $681 reported for 2025 was more than what 78% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $477 · 2022: $95.45 · 2023: $2,844 · 2024: $3,685 · 2025: $681.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $6,000 · Food and Beverage: $1,210.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $6,000.00 |
| Food and Beverage | $1,210.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eli Lilly and Company | $3,300.00 | 2024 | Verzenio |
| Lilly USA, LLC | $2,700.00 | 2023 | |
| Novartis Pharmaceuticals Corporation | $195.63 | 2021-2025 | |
| Merck Sharp & Dohme LLC | $159.81 | 2021-2025 | Keytruda, Lynparza |
| Janssen Biotech, INC. | $126.22 | 2021-2025 | Darzalex, Tecvayli, Talvey |
| Alexion Pharmaceuticals, INC. | $117.56 | 2023-2025 | Ultomiris |
| Daiichi Sankyo INC. | $89.10 | 2022-2025 | Vanflyta, Enhertu |
| Stemline Therapeutics INC. | $78.80 | 2024-2025 | Orserdu, Elzonris |
| Geron Corporation | $66.69 | 2025 | Rytelo |
| Menarini Silicon Biosystems, INC. | $56.86 | 2023-2024 | Cellsearch |
| Genzyme Corporation | $51.92 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $49.48 | 2021-2025 | |
| Amgen INC. | $46.82 | 2021-2022 | |
| Tempus Ai, INC | $45.10 | 2025 | Xt Cdx |
| Janssen Scientific Affairs, LLC | $44.83 | 2025 | Rybrevant |
Show all 39 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Virginia Ott listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.